Literature DB >> 15373910

Hepatic interleuklin 15 (IL-15) expression: implications for local NK/NKT cell homeostasis and development.

L Golden-Mason1, A M Kelly, D G Doherty, O Traynor, G McEntee, J Kelly, J E Hegarty, C O'Farrelly.   

Abstract

Interleukin 15 (IL-15) is critical for the development of human and murine natural killer (NK) cells and hepatic-derived NK T cells (NKT) in mice, and for the homeostatic maintenance of NK/NKT and CD8(+) memory T cells. The lymphocyte repertoire of an adult human liver includes significant populations of NK and NKT-like cells, which may arise locally from hepatic haematopoietic stem cells (HSCs). We investigated hepatic IL-15 levels and the expression of IL-2/IL-15-receptor beta-chain (IL-2/IL-15Rbeta; CD122) on mature hepatic lymphocytes and HSCs. Reverse transcription-polymerase chain reaction (RT-PCR) was used to detect secreted/intracellular IL-15 transcripts. IL-15 protein was localized using immunohistochemistry; levels were measured by enzyme-linked immunosorbent assay IL-2/IL-15Rbeta expression by flow-cytometry. Normal hepatic IL-15 protein was detected at 0.43 ng/100 mg total protein (n = 11, range 0.10 ng-0.9 ng). There was a significant increase in HCV-infected tissue (1.78 ng, P < 0.005, n = 11, range 0.18-2.43 ng). The staining pattern suggests that infiltrating monocytes and tissue resident Kupffer cells are the main producers. IL-15 protein was detected in supernatants from cultured liver biopsy specimens in the absence of stimulation (mean 175.8 pg/100 mg wet tissue, n = 3), which increased significantly upon stimulation (P < 0.05, mean 231.21 pg). On average, 61% of hepatic HSCs expressed IL-2/IL-15Rbeta suggesting a local lymphopoietic role. Eighty per cent of NK and 45.8% of CD56(+) T cells expressed IL-2/IL-15Rbeta, suggesting involvement in local CD56(+) cell activation and expansion. Constitutive expression of IL-15 protein and IL-2/IL-15Rbeta on hepatic lymphocytes suggests a key role in the generation and maintenance of the unique hepatic lymphoid repertoire. The significant increase observed in HCV-infected liver suggests a role for IL-15 in host antiviral responses in the liver.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15373910      PMCID: PMC1809196          DOI: 10.1111/j.1365-2249.2004.02586.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor-bearing adult human liver.

Authors:  L Golden-Mason; M P Curry; N Nolan; O Traynor; G McEntee; J Kelly; J E Hegarty; C O'Farrelly
Journal:  Hepatology       Date:  2000-06       Impact factor: 17.425

2.  Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire.

Authors:  J J Campbell; S Qin; D Unutmaz; D Soler; K E Murphy; M R Hodge; L Wu; E C Butcher
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  Isolation of lymphocytes from normal adult human liver suitable for phenotypic and functional characterization.

Authors:  M P Curry; S Norris; L Golden-Mason; D G Doherty; T Deignan; C Collins; O Traynor; G P McEntee; J E Hegarty; C O'Farrelly
Journal:  J Immunol Methods       Date:  2000-08-28       Impact factor: 2.303

Review 4.  Interleukin-2 and interleukin-15: immunotherapy for cancer.

Authors:  Todd A Fehniger; Megan A Cooper; Michael A Caligiuri
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

Review 5.  Innate and adaptive lymphoid cells in the human liver.

Authors:  D G Doherty; C O'Farrelly
Journal:  Immunol Rev       Date:  2000-04       Impact factor: 12.988

6.  Expression of cytokines and factors modulating apoptosis by human sinusoidal leucocytes.

Authors:  J R Jonsson; C J Edwards-Smith; S C Catania; Y Morotomi; P G Hogan; A D Clouston; A S Bansal; S V Lynch; R W Strong; E E Powell
Journal:  J Hepatol       Date:  2000-03       Impact factor: 25.083

7.  Expression of interleukin 7 (IL-7) mRNA and protein in the normal adult human liver: implications for extrathymic T cell development.

Authors:  L Golden-Mason; A M Kelly; O Traynor; G McEntee; J Kelly; J E Hegarty; C O'Farrelly
Journal:  Cytokine       Date:  2001-05-07       Impact factor: 3.861

8.  Control of homeostasis of CD8+ memory T cells by opposing cytokines.

Authors:  C C Ku; M Murakami; A Sakamoto; J Kappler; P Marrack
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

9.  Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.

Authors:  J Dunne; S Lynch; C O'Farrelly; S Todryk; J E Hegarty; C Feighery; D G Doherty
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

Review 10.  The role of interleukin 15 in mounting an immune response against microbial infections.

Authors:  Y Yoshikai; H Nishimura
Journal:  Microbes Infect       Date:  2000-04       Impact factor: 2.700

View more
  32 in total

1.  Hepatocyte-specific PPARA expression exclusively promotes agonist-induced cell proliferation without influence from nonparenchymal cells.

Authors:  Chad N Brocker; Jiang Yue; Donghwan Kim; Aijuan Qu; Jessica A Bonzo; Frank J Gonzalez
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-01-12       Impact factor: 4.052

2.  Distinct PLZF+CD8αα+ Unconventional T Cells Enriched in Liver Use a Cytotoxic Mechanism to Limit Autoimmunity.

Authors:  Huiming Sheng; Idania Marrero; Igor Maricic; Shaohsuan S Fanchiang; Sai Zhang; Derek B Sant'Angelo; Vipin Kumar
Journal:  J Immunol       Date:  2019-09-25       Impact factor: 5.422

3.  Interleukin-15 receptor α on hepatic stellate cells regulates hepatic fibrogenesis in mice.

Authors:  Jingjing Jiao; Kohtaro Ooka; Holger Fey; Maria Isabel Fiel; Adeeb H Rahmman; Kensuke Kojima; Yujin Hoshida; Xintong Chen; Tatiana de Paula; Diana Vetter; David Sastre; Ka Hin Lee; Youngmin Lee; Meena Bansal; Scott L Friedman; Miriam Merad; Costica Aloman
Journal:  J Hepatol       Date:  2016-05-03       Impact factor: 25.083

Review 4.  You Shall Not Pass: Memory CD8 T Cells in Liver-Stage Malaria.

Authors:  Mitchell N Lefebvre; John T Harty
Journal:  Trends Parasitol       Date:  2019-12-13

5.  Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease.

Authors:  Zhao-Hui Tang; Shuwen Liang; James Potter; Xuan Jiang; Hai-Quan Mao; Zhiping Li
Journal:  J Immunol       Date:  2013-01-07       Impact factor: 5.422

6.  Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome.

Authors:  Heather L Stevenson; Mark D Estes; Nagaraja R Thirumalapura; David H Walker; Nahed Ismail
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

7.  IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Rα production.

Authors:  Shinichiro Yokota; Osamu Yoshida; Lei Dou; Anthony V Spadaro; Kumiko Isse; Mark A Ross; Donna B Stolz; Shoko Kimura; Qiang Du; Anthony J Demetris; Angus W Thomson; David A Geller
Journal:  J Immunol       Date:  2015-05-11       Impact factor: 5.422

8.  The survival of memory CD8 T cells that is mediated by IL-15 correlates with sustained protection against malaria.

Authors:  Stasya Zarling; Dmitriy Berenzon; Sarat Dalai; Dmitry Liepinsh; Nick Steers; Urszula Krzych
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

9.  Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.

Authors:  Damien Sène; Franck Levasseur; Michal Abel; Marion Lambert; Xavier Camous; Céline Hernandez; Véronique Pène; Arielle R Rosenberg; Evelyne Jouvin-Marche; Patrice N Marche; Patrice Cacoub; Sophie Caillat-Zucman
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

10.  Expression profile and kinetics of cytokines and chemokines in patients with chronic hepatitis C.

Authors:  Zhen-Qi Han; Tao Huang; Yong-Zhi Deng; Guang-Ze Zhu
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.